We've found
184,457
clinical trials
We've found
184,457
clinical trials
Oncology Clinical Trial
Updated: 12/31/1969
Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Metastatic Alveolar Soft Part Sarcoma Clinical Trial
Updated: 12/31/1969
Atezolizumab in Treating Patients With Newly Diagnosed and Metastatic Alveolar Soft Part Sarcoma That Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Metastatic Alveolar Soft Part Sarcoma Clinical Trial
Updated: 12/31/1969
Atezolizumab in Treating Patients With Newly Diagnosed and Metastatic Alveolar Soft Part Sarcoma That Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Metastatic Alveolar Soft Part Sarcoma Clinical Trial
Updated: 12/31/1969
Atezolizumab in Treating Patients With Newly Diagnosed and Metastatic Alveolar Soft Part Sarcoma That Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Metastatic Alveolar Soft Part Sarcoma Clinical Trial
Updated: 12/31/1969
Atezolizumab in Treating Patients With Newly Diagnosed and Metastatic Alveolar Soft Part Sarcoma That Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/20/2017
CBT-101 Study for Advanced Solid Tumors and c-Met Dysregulation
Status: Enrolling,
Phase
I
Updated: 12/20/2017
Click here to add this to my saved trials

Psoriasis Clinical Trial
Updated: 7/18/2017
MAP Study: Methotrexate and Adalimumab in Psoriasis
Status: Enrolling,
Phase
II, III
Updated: 7/18/2017
Click here to add this to my saved trials

Psoriasis Clinical Trial
Updated: 7/18/2017
MAP Study: Methotrexate and Adalimumab in Psoriasis
Status: Enrolling,
Phase
II, III
Updated: 7/18/2017
Click here to add this to my saved trials

Lung Cancer Clinical Trial
Updated: 12/31/1969
Pembrolizumab (Immunotherapy Drug) in Combination With Guadecitabine and Mocetinostat (Epigenetic Drugs) for Patients With Advanced Lung Cancer.
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Lung Cancer Clinical Trial
Updated: 12/31/1969
Pembrolizumab (Immunotherapy Drug) in Combination With Guadecitabine and Mocetinostat (Epigenetic Drugs) for Patients With Advanced Lung Cancer.
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Laryngotracheal Stenosis Clinical Trial
Updated: 12/31/1969
Assessment of Primary Oxygenation and Airflow Measurement for Endoscopic Laryngeal Surgery
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Von Willebrand Factor Deficiency Clinical Trial
Updated: 12/31/1969
Low VW Activity in Adolescent HMB
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Von Willebrand Factor Deficiency Clinical Trial
Updated: 12/31/1969
Low VW Activity in Adolescent HMB
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Traumatic Brain Injury Clinical Trial
Updated: 12/31/1969
Functional Connectivity as a Biomarker of rTMS
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Oncology, Other Clinical Trial
Updated: 12/31/1969
Hearing Loss and the Effects of Statin Drugs in People With Head and Neck Squamous Cell Carcinoma Treated With Cisplatin Chemoradiation
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Ophthalmology, Rheumatology Clinical Trial
Updated: 12/31/1969
Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Ophthalmology, Rheumatology Clinical Trial
Updated: 12/31/1969
Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Ophthalmology, Rheumatology Clinical Trial
Updated: 12/31/1969
Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Ophthalmology, Rheumatology Clinical Trial
Updated: 12/31/1969
Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Defect of Articular Cartilage Clinical Trial
Updated: 12/31/1969
HyaloFAST Trial for Repair of Articular Cartilage in the Knee
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Defect of Articular Cartilage Clinical Trial
Updated: 12/31/1969
HyaloFAST Trial for Repair of Articular Cartilage in the Knee
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

GIST With D842V Mutated PDGFRA Gene Clinical Trial
Updated: 12/31/1969
Randomized Trial of Crenolanib in Subjects With D842V Mutated GIST
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Pharmacology / Toxicology Clinical Trial
Updated: 12/31/1969
Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-913 in Subjects With MPS II
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Skin Cancer Clinical Trial
Updated: 12/31/1969
Sun Safety Ink! A Sun Safety Program for the Tattoo Community
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clostridium Difficile Infection Clinical Trial
Updated: 12/31/1969
Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clostridium Difficile Infection Clinical Trial
Updated: 12/31/1969
Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clostridium Difficile Infection Clinical Trial
Updated: 12/31/1969
Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clostridium Difficile Infection Clinical Trial
Updated: 12/31/1969
Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clostridium Difficile Infection Clinical Trial
Updated: 12/31/1969
Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Musculoskeletal, Rheumatology Clinical Trial
Updated: 12/31/1969
Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Brain and Central Nervous System Tumors Clinical Trial
Updated: 12/31/1969
A Study Assessing BGB-290 With Radiation and/or Temozolomide (TMZ) in Subjects With Newly Diagnosed or Recurrent Glioblastoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Brain and Central Nervous System Tumors Clinical Trial
Updated: 12/31/1969
A Study Assessing BGB-290 With Radiation and/or Temozolomide (TMZ) in Subjects With Newly Diagnosed or Recurrent Glioblastoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Brain and Central Nervous System Tumors Clinical Trial
Updated: 12/31/1969
A Study Assessing BGB-290 With Radiation and/or Temozolomide (TMZ) in Subjects With Newly Diagnosed or Recurrent Glioblastoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Brain and Central Nervous System Tumors Clinical Trial
Updated: 12/31/1969
A Study Assessing BGB-290 With Radiation and/or Temozolomide (TMZ) in Subjects With Newly Diagnosed or Recurrent Glioblastoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Brain and Central Nervous System Tumors Clinical Trial
Updated: 12/31/1969
A Study Assessing BGB-290 With Radiation and/or Temozolomide (TMZ) in Subjects With Newly Diagnosed or Recurrent Glioblastoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Brain and Central Nervous System Tumors Clinical Trial
Updated: 12/31/1969
A Study Assessing BGB-290 With Radiation and/or Temozolomide (TMZ) in Subjects With Newly Diagnosed or Recurrent Glioblastoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Fluorescein Angiography Clinical Trial
Updated: 12/31/1969
Fluorescein Angiography With a Full-dose Versus a Half-dose of Intravenous Fluorescein
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Acute Respiratory Failure Clinical Trial
Updated: 12/31/1969
Nutrition and Exercise in Critical Illness
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Acute Respiratory Failure Clinical Trial
Updated: 12/31/1969
Nutrition and Exercise in Critical Illness
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Non-Small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
Osimertinib and Gefitinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Combination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid Leukemia
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Heart Failure With Preserved Ejection Fraction Clinical Trial
Updated: 12/31/1969
A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Heart Failure With Preserved Ejection Fraction Clinical Trial
Updated: 12/31/1969
A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Heart Failure With Preserved Ejection Fraction Clinical Trial
Updated: 12/31/1969
A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Heart Failure With Preserved Ejection Fraction Clinical Trial
Updated: 12/31/1969
A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology, Ophthalmology Clinical Trial
Updated: 12/31/1969
Study to Evaluate the Safety and Tolerability of Avelumab in Combination With Other Anti-Cancer Therapies in Patients With Advanced Malignancies
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Atezolizumab, Guadecitabine, and CDX-1401 Vaccine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Atezolizumab, Guadecitabine, and CDX-1401 Vaccine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
